A tighter archive for life-science signals.
Search once, then narrow by source or topic.
Lonza Group Ltd: Strong Growth Prospects and Attractive Valuation Support Buy Rating - TipRanks
Lonza Group Ltd: Strong Growth Prospects and Attractive Valuation Support Buy Rating TipRanks
Earnings call transcript: Lonza Group Q3 2025 sees strong CDMO growth - Investing.com
Earnings call transcript: Lonza Group Q3 2025 sees strong CDMO growth Investing.com
Lonza Reports Strong Q3 2025 and Confirms Full-Year Outlook - TipRanks
Lonza Reports Strong Q3 2025 and Confirms Full-Year Outlook TipRanks
Lonza’s UC-II Collagen earns NutraStrong certification, backed by clinical evidence on knee flexibility - Nutritional Outlook
Lonza’s UC-II Collagen earns NutraStrong certification, backed by clinical evidence on knee flexibility Nutritional Outlook
Lonza CHI receives NutraStrong Collagen Verified certification - nutritioninsight.com
Lonza CHI receives NutraStrong Collagen Verified certification nutritioninsight.com
Earnings call transcript: Lonza Confirms Strong 2025 Outlook in Q1 2025 - Investing.com
Earnings call transcript: Lonza Confirms Strong 2025 Outlook in Q1 2025 Investing.com
While Lonza's sales slipped in '24, CDMO touts stronger position heading into new year - Fierce Pharma
While Lonza's sales slipped in '24, CDMO touts stronger position heading into new year Fierce Pharma
Brand directory, kept in view
A rolling strip of the companies, platforms, CROs and device makers that show up across the coverage.
Open about page